Inozyme Pharma, Inc. (INZY)
Data as of , from SEC Form 4 filings.
See up to 3 months of INZY. The 7-day demo opens the 1M and 3M ranges and puts INZY on your watchlist.
Start 7-day demoLatest INZY insider trades
Sanjay Subramanian - OfficerOther$159K- Sanjay Subramanian - OfficerDerivative
About Inozyme Pharma, Inc. (INZY)
The SEC lists Inozyme Pharma, Inc. under CIK 0001693011, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
INZY Form 4 activity by transaction type, last 90 days
No Form 4 activity for INZY in the last 90 days.
INZY insider transactions (Form 4)
219 Form 4 filings on record, the earliest from Oct 3, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sanjay Subramanian - Officer | Other | Common Stock | 39,701 | $4.00 | $159K | |
| Sanjay Subramanian - Officer | Derivative | Restricted Stock Units | 38,500 | - | - | |
| Sanjay Subramanian - Officer | Derivative | Stock Option (Right to Buy) | 180,000 | - | - | |
| Sanjay Subramanian - Officer | Derivative | Stock Option (Right to Buy) | 135,000 | - | - | |
| Sanjay Subramanian - Officer | Derivative | Stock Option (Right to Buy) | 145,000 | - | - | |
| Matthew Winton - Officer | Other | Common Stock | 21,743 | $4.00 | $87K | |
| Matthew Winton - Officer | Derivative | Restricted Stock Units | 41,500 | - | - | |
| Matthew Winton - Officer | Derivative | Stock Option (Right to Buy) | 145,000 | - | - | |
| Lynne Marie Sullivan | Derivative | Stock Option (Right to Buy) | 28,368 | - | - | |
| Douglas A. Treco - Officer | Other | Common Stock | 43,861 | $4.00 | $175K | |
| Douglas A. Treco - Officer | Derivative | Restricted Stock Units | 150,000 | - | - | |
| Douglas A. Treco - Officer | Derivative | Stock Option (Right to Buy) | 86,979 | - | - | |
| Douglas A. Treco - Officer | Derivative | Stock Option (Right to Buy) | 400,000 | - | - | |
| Axel Bolte | Other | Common Stock | 423,926 | $4.00 | $1.70M | |
| Axel Bolte | Derivative | Stock Option (Right to Buy) | 234,176 | - | - | |
| Axel Bolte | Derivative | Stock Option (Right to Buy) | 159,187 | - | - | |
| Robert Lorne Hopfner | Other | Common Stock | 2,923,110 | $4.00 | $11.69M | |
| Robert Lorne Hopfner | Other | Common Stock | 1,571,741 | $4.00 | $6.29M | |
| Erik Harris | Grant or award | Stock Option (right to buy) | 56,000 | $0.00 | - | |
| Matthew Winton - Officer | Grant or award | Common Stock | 1,710 | $4.45 | $8K | |
| Douglas A. Treco - Officer | Grant or award | Common Stock | 1,710 | $4.45 | $8K |
INZY insider trading FAQ
What is the latest insider trade for INZY?
Inozyme Pharma, Inc. (INZY) has filed no insider reports in the last 90 days. The most recent on record is dated 1 July 2025. The full record for INZY runs to 9 Form 4 filings, the earliest from 3 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INZY stock?
No insider purchases of INZY were filed in the last 90 days.
How many insiders are selling INZY stock?
No insider sales of INZY were filed in the last 90 days.
Where can I see INZY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INZY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Sanjay Subramanian view on EDGAR
- - Matthew Winton view on EDGAR
- - Lynne Marie Sullivan view on EDGAR
- - Douglas A. Treco view on EDGAR
- - Axel Bolte view on EDGAR
- - Robert Lorne Hopfner view on EDGAR
- - Erik Harris view on EDGAR
- - Matthew Winton view on EDGAR
- - Douglas A. Treco view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where INZY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INZY with a 7-day demo
- INZY on your watchlist
- Every INZY Form 4 filing on record
- Up to 3 months of INZY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
